Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 166–180 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5156 KRT14 Gene Epidermolysis Bullosa Simplex, Weber-Cockayne Type NGS Test This test evaluates the KRT14 gene for variants associated with Weber-Cockayne type epidermolysis bullosa simplex (EBS-WC).	Peripheral whole blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KRT14 gene variants", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Continue prescribed medications unless advised otherwise by your doctor"] Indications ["Suspected diagnosis of Weber-Cockayne type epidermolysis bullosa simplex", "Family screening for EBS-WC", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 92939-7 ICD-10: Q81.0, Z84.8, Z15.89 Clinical summary This test evaluates the KRT14 gene for variants associated with Weber-Cockayne type epidermolysis bullosa simplex (EBS-WC).
TEST-4781 KRT14 Gene Naegeli-Franceschetti-Jadassohn Syndrome Genetic Test This genetic test analyzes the KRT14 gene to detect mutations associated with Naegeli-Franceschetti-Jadassohn syndrome (NFJS).	Peripheral Whole Blood (3–5 mL in EDTA tube); alternative buccal swab accepted for paediatric cases	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Point mutations in KRT14 gene", "Small insertions/deletions in KRT14 gene", "Copy number variants in KRT14 gene"] Parameters [] Preparation ["No fasting required", "Provide complete clinical summary and family pedigree at time of collection"] Indications ["Suspected diagnosis of Naegeli-Franceschetti-Jadassohn syndrome (NFJS)", "Clinical presentation consistent with ectodermal dysplasia", "Family history of NFJS"] Measurement technique Confirm with laboratory Codes LOINC: 94761-6 ICD-10: Q82.8 Clinical summary This genetic test analyzes the KRT14 gene to detect mutations associated with Naegeli-Franceschetti-Jadassohn syndrome (NFJS).
TEST-4681 KRT16 Gene Pachyonychia Congenita Type 1 Genetic Test This genetic test evaluates the KRT16 gene for pathogenic variants associated with Pachyonychia Congenita Type 1.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KRT16 gene"] Parameters [] Preparation ["No fasting or special preparation is required."] Indications ["Suspected Pachyonychia Congenita Type 1", "Family screening for PC-1", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 94477-7 ICD-10: Q84.5, Z15.09, Z13.79 Clinical summary This genetic test evaluates the KRT16 gene for pathogenic variants associated with Pachyonychia Congenita Type 1.
TEST-4550 KRT17 Gene Steatocystoma Multiplex Genetic Test This genetic test identifies pathogenic variants in the KRT17 gene associated with steatocystoma multiplex.	Whole Blood (EDTA) or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KRT17 gene"] Parameters [] Preparation ["Avoid anticoagulants before blood draw", "Do not alter prescribed medication without physician approval"] Indications ["Confirmation of steatocystoma multiplex diagnosis", "Familial risk assessment", "Genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 21644-0 ICD-10: L72.2 Clinical summary This genetic test identifies pathogenic variants in the KRT17 gene associated with steatocystoma multiplex.
TEST-4988 KRT71 Gene Hypotrichosis Type 13 Genetic Test This test evaluates the KRT71 gene for pathogenic variants associated with hypotrichosis type 13, a form of hereditary hair loss.	Peripheral whole blood (EDTA tube) or FTA card	21–28 days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KRT71 gene", "Coding region and splice sites of KRT71"] Parameters [] Preparation [] Indications ["Individuals with suspected hypotrichosis type 13", "Family history of hereditary hair loss"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q84.0, L65.0 Clinical summary This test evaluates the KRT71 gene for pathogenic variants associated with hypotrichosis type 13, a form of hereditary hair loss.
TEST-4849 LAMA3 Gene Laryngo-Onycho-Cutaneous Syndrome (LOCS) Genetic Test This test evaluates the LAMA3 gene for pathogenic mutations associated with Laryngo-Onycho-Cutaneous Syndrome (LOCS). It identifies variants linked to skin fragility, nail dystroph...	Peripheral Blood, Extracted DNA, or FTA Card Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LAMA3 gene sequence", "Pathogenic mutations (small variants, deletions, duplications)", "Copy Number Variations (CNV)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}, {"name": "Analytical Specificity", "reference_range": "99.9%"}] Preparation ["No fasting required", "No medication adjustments required"] Indications ["Suspected diagnosis of Laryngo-Onycho-Cutaneous Syndrome (LOCS)", "Family history of LOCS", "Need for cancer surveillance planning in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 82319-3 ICD-10: Q81.8 Clinical summary This test evaluates the LAMA3 gene for pathogenic mutations associated with Laryngo-Onycho-Cutaneous Syndrome (LOCS). It identifies variants linked to skin fragility, nail dystrophy, laryngeal granulation tissue, and increased squamous cell carcinoma risk.
TEST-2941 LAMC3 Gene Cortical Malformations, Occipital Genetic Test This test detects pathogenic variants in the LAMC3 gene associated with occipital cortical malformations.	Peripheral whole blood (EDTA) or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Large deletions/duplications (CNV)"] Parameters [] Preparation ["Genetic counselling is mandatory prior to sample submission.", "A detailed family pedigree must be provided."] Indications ["Suspected occipital cortical malformations", "Autosomal recessive occipital polymicrogyria", "Severe neurodevelopmental disorder with relevant clinical features"] Measurement technique Confirm with laboratory Codes LOINC: 62374-4 ICD-10: Q04.8 Clinical summary This test detects pathogenic variants in the LAMC3 gene associated with occipital cortical malformations.
TEST-5562 LARS2 Gene Perrault Syndrome Type 4 Genetic Test This genetic test identifies pathogenic variants in the LARS2 gene associated with Perrault syndrome type 4.	Blood, Extracted DNA, or One-Drop Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LARS2 gene"] Parameters [] Preparation ["Provide detailed clinical history", "Genetic counselling session mandatory", "No special fasting required", "Continue prescribed treatments unless advised otherwise"] Indications ["Suspected Perrault syndrome type 4", "Family history of Perrault syndrome type 4"] Measurement technique Confirm with laboratory Codes LOINC: 93929-0 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic variants in the LARS2 gene associated with Perrault syndrome type 4.
TEST-6081 LDHB Gene (Lactate Dehydrogenase B Deficiency) Genetic Test This genetic test identifies pathogenic variants in the LDHB gene associated with lactate dehydrogenase B deficiency.	Whole blood (peripheral) or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LDHB gene", "Single nucleotide variants", "Small indels"] Parameters [] Preparation ["No specific fasting required", "No medication or diet modifications needed"] Indications ["Confirmation of clinical suspicion of LDHB deficiency", "Family screening for LDHB deficiency", "Personalized management of metabolic myopathies"] Measurement technique Confirm with laboratory Codes LOINC: 88247-9 ICD-10: E74.09, R82.3 Clinical summary This genetic test identifies pathogenic variants in the LDHB gene associated with lactate dehydrogenase B deficiency.
TEST-2791 LMNA Gene Heart-Hand Syndrome (Slovenian Type) Genetic Test This genetic test identifies pathogenic variants within the LMNA gene associated with Heart-Hand syndrome, Slovenian type.	Peripheral Blood Sample	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LMNA gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting your physician"] Indications ["Suspected Heart-Hand syndrome, Slovenian type", "Family history of Heart-Hand syndrome, Slovenian type", "Genetic counselling for reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 21623-6 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic variants within the LMNA gene associated with Heart-Hand syndrome, Slovenian type.
TEST-2372 MAGEL2 Gene Schaaf-Yang Syndrome Genetic Test This test identifies disease-causing mutations in the MAGEL2 gene, confirming Schaaf‑Yang syndrome.	Whole Blood or FTA Card (Peripheral Blood)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MAGEL2 gene sequence", "Mutations in MAGEL2"] Parameters [] Preparation ["Genetic counselling before testing is mandatory", "No specific fasting or medication instructions mentioned"] Indications ["Suspected Schaaf‑Yang syndrome", "Neonates and infants with arthrogryposis, profound hypotonia, feeding difficulties, and developmental delay", "Familial variant screening", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 86388-0 ICD-10: Q87.8 Clinical summary This test identifies disease-causing mutations in the MAGEL2 gene, confirming Schaaf‑Yang syndrome.
TEST-4958 MAGT1 Gene Mental Retardation, X‑Linked Type 95 (XLMR‑95) Genetic Test This test identifies pathogenic variants in the MAGT1 gene associated with X-linked mental retardation type 95 (XLMR-95). It uses Next-Generation Sequencing (NGS) for high sensitiv...	Peripheral Whole Blood or Dried Blood Spot (DBS) Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MAGT1 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"] Parameters [] Preparation [] Indications ["Suspected X-linked intellectual disability", "Family history of X-linked neurodevelopmental disorders", "Carrier testing in at-risk female relatives"] Measurement technique Confirm with laboratory Codes LOINC: 94244-2 ICD-10: F78.8 Clinical summary This test identifies pathogenic variants in the MAGT1 gene associated with X-linked mental retardation type 95 (XLMR-95). It uses Next-Generation Sequencing (NGS) for high sensitivity and accuracy.
TEST-2714 MAMLD1 Gene Hypospadias Type 2, X-Linked Genetic Test This test identifies pathogenic variants in the MAMLD1 gene associated with X-linked hypospadias type 2.	Whole blood (EDTA tube) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MAMLD1 gene sequence", "Exons and flanking splice sites of MAMLD1"] Parameters [] Preparation [] Indications ["Diagnosis of X-linked hypospadias type 2", "Recurrence risk assessment", "Familial genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q54.2, Q54.8 Clinical summary This test identifies pathogenic variants in the MAMLD1 gene associated with X-linked hypospadias type 2.
TEST-6044 MANBA Gene Beta‑Mannosidosis Genetic Test This genetic test analyzes the MANBA gene for mutations associated with beta-mannosidosis.	Whole Blood, Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MANBA gene pathogenic variants", "Single nucleotide variants", "Small indels"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your physician"] Indications ["Confirmation of suspected beta-mannosidosis diagnosis", "Carrier screening", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 77641-7 ICD-10: E77.1, Z14.8, Z31.430 Clinical summary This genetic test analyzes the MANBA gene for mutations associated with beta-mannosidosis.
TEST-5127 MATN3 Gene Multiple Epiphyseal Dysplasia Type 5 Genetic Test This genetic test identifies pathogenic mutations in the MATN3 gene, confirming a diagnosis of multiple epiphyseal dysplasia type 5.	Whole blood or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MATN3 gene mutations", "Point mutations", "Small insertions/deletions", "Copy number variants"] Parameters [] Preparation [] Indications ["Diagnosis of multiple epiphyseal dysplasia type 5", "Family planning for at-risk individuals", "Management guidance"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q77.8 Clinical summary This genetic test identifies pathogenic mutations in the MATN3 gene, confirming a diagnosis of multiple epiphyseal dysplasia type 5.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.